Renaissance Technologies LLC Cuts Stake in Phibro Animal Health Corp (NASDAQ:PAHC)

Renaissance Technologies LLC lowered its position in shares of Phibro Animal Health Corp (NASDAQ:PAHC) by 2.9% in the second quarter, Holdings Channel reports. The institutional investor owned 756,500 shares of the company’s stock after selling 22,600 shares during the period. Renaissance Technologies LLC’s holdings in Phibro Animal Health were worth $24,034,000 as of its most recent filing with the SEC.

Other institutional investors have also recently made changes to their positions in the company. Laurion Capital Management LP grew its stake in shares of Phibro Animal Health by 23.3% during the 1st quarter. Laurion Capital Management LP now owns 10,317 shares of the company’s stock worth $340,000 after purchasing an additional 1,949 shares during the period. Swiss National Bank grew its stake in shares of Phibro Animal Health by 2.4% during the 2nd quarter. Swiss National Bank now owns 37,800 shares of the company’s stock worth $1,201,000 after purchasing an additional 900 shares during the period. Campbell & CO Investment Adviser LLC grew its stake in shares of Phibro Animal Health by 30.0% during the 1st quarter. Campbell & CO Investment Adviser LLC now owns 10,667 shares of the company’s stock worth $352,000 after purchasing an additional 2,462 shares during the period. Martingale Asset Management L P grew its stake in shares of Phibro Animal Health by 15.7% during the 1st quarter. Martingale Asset Management L P now owns 153,745 shares of the company’s stock worth $5,075,000 after purchasing an additional 20,898 shares during the period. Finally, Financial Gravity Wealth Inc. acquired a new position in shares of Phibro Animal Health during the 2nd quarter worth $38,000. Institutional investors own 51.70% of the company’s stock.

In other Phibro Animal Health news, Director E Thomas Corcoran acquired 5,000 shares of the stock in a transaction that occurred on Friday, August 30th. The shares were purchased at an average cost of $21.21 per share, with a total value of $106,050.00. Following the purchase, the director now owns 15,000 shares in the company, valued at $318,150. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 50.29% of the stock is currently owned by corporate insiders.



PAHC has been the topic of a number of recent analyst reports. Bank of America lowered their price target on shares of Phibro Animal Health from $29.00 to $18.00 and set an “underperform” rating on the stock in a research note on Thursday, August 29th. ValuEngine cut shares of Phibro Animal Health from a “hold” rating to a “sell” rating in a research note on Wednesday, August 28th. Barclays lowered their price target on shares of Phibro Animal Health from $25.00 to $18.00 and set an “underweight” rating on the stock in a research note on Thursday, August 29th. TheStreet cut shares of Phibro Animal Health from a “b-” rating to a “c+” rating in a research note on Tuesday, September 10th. Finally, Guggenheim initiated coverage on shares of Phibro Animal Health in a research note on Thursday, May 23rd. They set a “neutral” rating on the stock. Three investment analysts have rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating to the company. Phibro Animal Health presently has an average rating of “Hold” and an average target price of $26.60.

NASDAQ PAHC traded up $0.81 during trading hours on Monday, reaching $22.21. The company’s stock had a trading volume of 67,478 shares, compared to its average volume of 340,962. The stock has a market cap of $891.92 million, a PE ratio of 14.52, a PEG ratio of 4.20 and a beta of 0.82. Phibro Animal Health Corp has a fifty-two week low of $20.00 and a fifty-two week high of $44.99. The company’s 50-day moving average is $27.61 and its two-hundred day moving average is $30.25. The company has a debt-to-equity ratio of 1.45, a quick ratio of 1.74 and a current ratio of 3.02.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings data on Tuesday, August 27th. The company reported $0.33 EPS for the quarter, missing the Zacks’ consensus estimate of $0.34 by ($0.01). The business had revenue of $203.90 million during the quarter, compared to analyst estimates of $206.00 million. Phibro Animal Health had a net margin of 6.59% and a return on equity of 29.99%. Phibro Animal Health’s revenue was down 3.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.46 earnings per share. Equities analysts expect that Phibro Animal Health Corp will post 1.12 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Wednesday, September 4th will be paid a $0.12 dividend. The ex-dividend date of this dividend is Tuesday, September 3rd. This represents a $0.48 dividend on an annualized basis and a yield of 2.16%. Phibro Animal Health’s payout ratio is 31.37%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

Further Reading: What causes a yield curve to invert?

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corp (NASDAQ:PAHC).

Institutional Ownership by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.